Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …

Neurological involvement in antiphospholipid antibody syndrome (APS) is common, and its
occurrence increases morbidity and mortality. Patients may present variable neurological …

Activated platelets release micromolar concentrations of the chemokine CXCL4/Platelet
Factor-4. Deposition of CXCL4 onto the vascular endothelium is involved in atherosclerosis …

Atherosclerosis is regarded as one of the leading causes of mortality and morbidity in the
world. Nowadays, it seems that atherosclerosis cannot be defined merely through the …

Objectives Cardiovascular diseaseand heart failure (CHF) are leading causes of death in
systemic lupus erythematosus (SLE). The underlying mechanisms for increased CHF in SLE …

Infectious myocarditis is the result of an immune response to a microbial infection of the
heart. The blood vessels of the heart, both the intramyocardial microvasculature and the …

Background: Psoriatic arthritis is a chronic inflammatory arthropathy that affects 14%-30% of
patients with skin and/or nail psoriasis, leading to severe physical limitations and disability. It …

Background Patients with systemic sclerosis (SSc) have high cardiovascular mortality even
though there is no or little increase in prevalence of epicardial coronary stenosis. First-pass …

Objective To investigate the incidence and clinical significance of cardiovascular disease in
systemic lupus erythematosus patients. Methods We included systemic lupus erythematosus …

Background. The aim of this study was to investigate the effect of anti‐TNF therapy on
glucose and lipid metabolism in nondiabetic, nonobese patients with inflammatory bowel …